56 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview ... #Interactions #Pharmacology
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
• Direct renin inhibitor ... Angiotensin-converting enzyme (ACE) inhibitors ... • Calcineurin Inhibitors ... differential #diagnosis #pathophysiology ... #pharmacology #
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Between P2Y12 Inhibitors ... Oral P2Y12 inhibitors ... Switching P2Y12 inhibitors ... Drug interactions ... ticagrelor #prasugrel #pharmacology
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir & Cobicistat 

Ritonavir & Cobicistat are 2 pharmacokinetic boosters used
are both CYP3A4 INHIBITORS ... actually a protease inhibitor ... and a 3A4 inhibitor ... is just a 3A4 inhibitor ... HIV #Boosters #Pharmacology
Synercid (Quinupristin/Dalfopristin) (IV) - Antibiotics Class Overview

Mechanism: “Streptogramins”– inhibits sequential steps in ribosomal synthesis
Spectrum: covers MRSA
Antibiotics Class Overview ... Streptogramins”– inhibits ... lots of drug-drug interactions ... (CYP450 inhibitor ... #Pharmacology #Antibiotics
Protease Inhibitors 

Protease Inhibitors are a class of commonly used antiretroviral medications for management of HIV.
Protease Inhibitors ... Protease Inhibitors ... Here's a broad overview ... cobicistat (3A4 INHIBITORS ... #Protease #Inhibitors
Drugs Interacting with Sulfonylureas

Drugs that may reduce the effects of sulfonylureas, leading to loss of glucose
Drugs Interacting ... sulfonylureas, leading ... Monoamine oxidase inhibitors ... #Interactions # ... Pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... Pglycoprotein #inducers #inhibitors ... #Table #Pharmacology
Inhibitors of Platelet Aggregation

#Antiplatelet #Inhibitors #Pharmacolgy #Pathophysiology #MechanismOfAction
Inhibitors of Platelet ... #Antiplatelet #Inhibitors ... #Pharmacolgy #Pathophysiology
Dabigatran Etexilate - direct acting thrombin inhibitor used in DVT/PE prophylaxis. Reversal agent: idarucizumab.

#Pharmacology #Dabigatran #Pradaxa
acting thrombin inhibitor ... #Pharmacology #Dabigatran ... DirectThrombin #Inhibitor ... #Overview #Review